loading

Tonix Pharmaceuticals Holding Corp Stock (TNXP) Forecast

The Tonix Pharmaceuticals Holding Corp (TNXP) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2,993.54, representing a +7,488% increase from the current price of $39.45. The highest analyst price target is $3,002.39, and the lowest is $2,984.68.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TNXP Price Target
Average 2,622.73 (+6,548% Upside)
loading

Is Tonix Pharmaceuticals Holding Corp (TNXP) A Buy Now?

Oscillators
Name Value Action
RSI(14) 70.13 Sell
STOCH(9,6) 84.35 Sell
STOCHRSI(14) 40.79 Neutral
MACD(12,26) 5.5651 Buy
ADX(14) 53.60 Buy
William %R -20.54 Neutral
CCI(14) 57.95 Neutral
Buy: 2 Sell: 2 Neutral: 3
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
35.82
Buy
36.06
Buy
MA20
29.21
Buy
31.33
Buy
MA50
22.81
Buy
25.25
Buy
MA100
20.86
Buy
29.07
Buy
MA200
21.23
Buy
116.05
Sell
Buy: 9 Sell: 1 Neutral: 0
Summary: Buy
According to our latest analysis, TNXP could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 3 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on TNXP, as trading bullish markets is always a lot easier
  1. RSI (Relative Strength Index): The RSI(14) value of 70.13 indicates that TNXP is overbought. This suggests that TNXP price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
  2. STOCH (Stochastic Oscillator): The STOCH value of 84.35 indicates that TNXP is oversold. This means that TNXP price is at or near the highest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 40.79 indicates that TNXP is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 53.6 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 57.95 indicates that TNXP is still overbought but not to an extreme extent.

Long-term TNXP price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Tonix Pharmaceuticals Holding Corp financial reports and earnings history, Tonix Pharmaceuticals Holding Corp (TNXP) stock could reach $4,424.62 by 2030, $2,629.66 by 2040 and $8,807.16 by 2050. See the projected annual prices until 2050 of the Tonix Pharmaceuticals Holding Corp stock below:

  • Tonix Pharmaceuticals Holding Corp (TNXP) is expected to reach an average price of $755.99 in 2035, with a high prediction of $863.89 and a low estimate of $756.01. This indicates an $1,816% rise from the last recorded price of $39.45.
  • Tonix Pharmaceuticals Holding Corp (TNXP) stock is projected to chart a bullish course in 2040, with an average price target of $2,508.69, representing an $6,259% surge from its current level. The forecast ranges from a conservative $2,509.31 to a sky-high $2,629.66.
  • Our analysts predict Tonix Pharmaceuticals Holding Corp (TNXP) to jump 12,900% by 2045, soaring from $5,128.33 to an average price of $5,128.32, potentially reaching $5,287.07. While $5,128.33 is the low estimate, the potential upside is significant.
  • Tonix Pharmaceuticals Holding Corp (TNXP) stock is expected to climb by 2050, reaching an average of $8,594.29, a $21,685% jump from its current level. However, a wide range of estimates exists, with high and low targets of $8,807.16 and $8,602.29, respectively, highlighting the market's uncertainty.

Tonix Pharmaceuticals Holding Corp Stock (TNXP) Year by Year Forecast

Tonix Pharmaceuticals Holding Corp Stock (TNXP) Price Forecast for 2025

Tonix Pharmaceuticals Holding Corp Stock (TNXP) is expected to reach an average price of $2,984.15 in 2025, with a high prediction of $3,277.07 and a low estimate of $2,691.24. This indicates an +7,464% rise from the last recorded price of $39.45.
Month Average Low High Change from today's price
July, 2025 $2,979.68 $2,984.68 $3,002.39 +7,453%
August, 2025 $2,923.37 $2,936.47 $2,960.18 +7,310%
September, 2025 $2,767.66 $2,773.66 $2,863.17 +6,916%
October, 2025 $2,764.95 $2,769.66 $2,756.66 +6,909%
November, 2025 $2,708.15 $2,716.35 $2,750.65 +6,765%
December, 2025 $2,696.25 $2,691.24 $2,696.64 +6,735%

Tonix Pharmaceuticals Holding Corp Stock (TNXP) Price Forecast for 2026

The predicted value for Tonix Pharmaceuticals Holding Corp (TNXP) in 2026 is set at an average of $2,331.33. Estimates vary from a peak of $2,671.13 to a trough of $1,991.52, indicating an +5,810% surge from the present price of $39.45.
Month Average Low High Change from today's price
January, 2026 $2,640.23 $2,648.63 $2,671.13 +6,593%
February, 2026 $2,578.22 $2,588.60 $2,615.12 +6,435%
March, 2026 $2,464.61 $2,492.51 $2,528.61 +6,147%
April, 2026 $2,295.10 $2,307.10 $2,419.11 +5,718%
May, 2026 $2,235.09 $2,281.09 $2,296.47 +5,566%
June, 2026 $2,235.08 $2,243.08 $2,236.08 +5,566%
July, 2026 $2,191.57 $2,213.07 $2,217.58 +5,455%
August, 2026 $2,083.56 $2,097.56 $2,158.07 +5,182%
September, 2026 $2,068.05 $2,083.55 $2,067.55 +5,142%
October, 2026 $2,090.02 $2,068.64 $2,081.12 +5,198%
November, 2026 $2,032.85 $2,036.03 $2,055.64 +5,053%
December, 2026 $1,986.14 $1,991.52 $2,011.53 +4,935%

Tonix Pharmaceuticals Holding Corp Stock (TNXP) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Tonix Pharmaceuticals Holding Corp (TNXP) is $1,683.46, with a high forecast of $1,971.02 and a low forecast of $1,395.91. This indicates an +4,167% increase from the last price of $39.45.
Month Average Low High Change from today's price
January, 2027 $1,942.67 $1,946.51 $1,971.02 +4,824%
February, 2027 $1,901.68 $1,902.10 $1,920.07 +4,720%
March, 2027 $1,848.05 $1,854.97 $1,871.60 +4,585%
April, 2027 $1,819.78 $1,821.98 $1,833.91 +4,513%
May, 2027 $1,779.33 $1,781.97 $1,805.74 +4,410%
June, 2027 $1,714.06 $1,719.02 $1,760.47 +4,245%
July, 2027 $1,655.41 $1,658.45 $1,693.98 +4,096%
August, 2027 $1,615.83 $1,616.25 $1,641.69 +3,996%
September, 2027 $1,565.93 $1,568.00 $1,601.34 +3,869%
October, 2027 $1,514.86 $1,515.74 $1,550.49 +3,740%
November, 2027 $1,461.48 $1,462.23 $1,499.49 +3,605%
December, 2027 $1,395.66 $1,395.91 $1,447.73 +3,438%

Tonix Pharmaceuticals Holding Corp Stock (TNXP) Price Forecast for 2028

In 2028, Tonix Pharmaceuticals Holding Corp (TNXP) is projected to reach an average price of $1,040.76, with a high projection of $1,380.59 and a low estimate of $700.92. This indicates an +2,538% rise from the last price of $39.45.
Month Average Low High Change from today's price
January, 2028 $1,344.20 $1,344.53 $1,380.59 +3,307%
February, 2028 $1,293.05 $1,293.14 $1,330.21 +3,178%
March, 2028 $1,226.06 $1,226.06 $1,279.01 +3,008%
April, 2028 $1,172.40 $1,172.52 $1,212.44 +2,872%
May, 2028 $1,105.28 $1,105.55 $1,158.88 +2,702%
June, 2028 $1,045.66 $1,047.29 $1,091.42 +2,551%
July, 2028 $992.78 $993.09 $1,031.78 +2,417%
August, 2028 $927.93 $928.02 $979.15 +2,252%
September, 2028 $874.13 $874.32 $913.83 +2,116%
October, 2028 $820.59 $820.97 $860.63 +1,980%
November, 2028 $754.42 $754.52 $807.00 +1,812%
December, 2028 $700.71 $700.92 $740.70 +1,676%

Tonix Pharmaceuticals Holding Corp Stock (TNXP) Price Forecast for 2029

The 2029 price forecast for Tonix Pharmaceuticals Holding Corp Stock (TNXP) is $1,906.58 on average, with a high prediction of $3,799.65 and a low estimate of $13.51. This represents an +4,733% increase from the previous price of $39.45.
Month Average Low High Change from today's price
January, 2029 $633.71 $633.71 $687.13 +1,506%
February, 2029 $579.85 $579.86 $620.18 +1,370%
March, 2029 $525.84 $525.88 $566.29 +1,233%
April, 2029 $472.17 $472.21 $512.33 +1,097%
May, 2029 $404.77 $404.81 $458.65 +926.04%
June, 2029 $350.70 $350.73 $391.24 +788.98%
July, 2029 $296.82 $296.84 $337.18 +652.40%
August, 2029 $229.39 $229.41 $283.28 +481.48%
September, 2029 $175.38 $175.40 $215.86 +344.57%
October, 2029 $107.85 $107.87 $161.81 +173.38%
November, 2029 $54.03 $54.07 $94.33 +36.95%
December, 2029 $3,969.65 $13.51 $3,799.65 +9,962%

Tonix Pharmaceuticals Holding Corp Stock (TNXP) Price Forecast for 2030

Tonix Pharmaceuticals Holding Corp Stock (TNXP) is expected to reach an average price of $5,675.07 in 2030, with a high forecast of $6,811.51 and a low forecast of $4,538.63. This signifies an +14,285% surge from the last price of $39.45.
Month Average Low High Change from today's price
January, 2030 $4,624.62 $4,538.63 $4,424.62 +11,623%
February, 2030 $5,486.61 $4,957.62 $5,176.61 +13,808%
March, 2030 $6,571.19 $6,529.60 $6,475.59 +16,557%
April, 2030 $6,630.17 $6,664.58 $6,616.37 +16,707%
May, 2030 $6,553.35 $6,497.56 $6,485.55 +16,512%
June, 2030 $6,437.73 $6,404.54 $6,376.33 +16,219%
July, 2030 $6,859.51 $6,643.52 $6,728.51 +17,288%
August, 2030 $6,774.49 $6,792.49 $6,811.51 +17,072%
September, 2030 $6,564.47 $6,634.47 $6,741.49 +16,540%
October, 2030 $6,663.91 $6,555.46 $6,652.79 +16,792%
November, 2030 $6,513.24 $6,471.72 $6,629.05 +16,410%
December, 2030 $6,397.66 $6,410.98 $6,414.64 +16,117%
$1.16
price up icon 0.87%
$31.13
price down icon 0.19%
$576.61
price down icon 1.37%
$303.77
price down icon 0.76%
$4.5807
price down icon 0.41%
$487.86
price up icon 0.56%
Cap:     |  Volume (24h):